Furiex Pharmaceuticals, Inc.·4

May 11, 4:52 PM ET

Furiex Pharmaceuticals, Inc. 4

4 · Furiex Pharmaceuticals, Inc. · Filed May 11, 2011

Insider Transaction Report

Form 4
Period: 2011-05-09
COVINGTON PAUL S
Senior VP-Clinical Operations
Transactions
  • Award

    Stock Options (to buy)

    2011-05-09+26,00026,000 total
    Exercise: $15.00Exp: 2021-05-09Common Stock (26,000 underlying)
Holdings
  • Stock Options (to buy)

    Exercise: $9.11Exp: 2020-06-17Common Stock (75,691 underlying)
    75,691
  • Common Stock

    73
Footnotes (2)
  • [F1]The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided that the Optionee's employment continues.
  • [F2]The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided that the Optionee's employment continues.

Documents

1 file
  • 4
    rrd302883.xmlPrimary

    FORM 4